New windows open for immunotherapy in lung cancer

Activating immune cells to destroy tumours is an effective strategy for treating an advanced lung cancer — but only for some people. Evidence that this approach has potential in early disease and as a combination therapy has now emerged. Activating immune cells to destroy tumours is an effective str...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 2018-06, Vol.558 (7710), p.376-377
Main Authors: Hendriks, Lizza, Besse, Benjamin
Format: Article
Language:English
Subjects:
631/250
631/67
692/308
Cancer genetics
Cancer research
Cancer treatment
Cancer Vaccines
Care and treatment
Chemotherapy
Enzymes
Genes
Humans
Immune system
Immunotherapy
Lung cancer
Lung Neoplasms
Neoadjuvant Therapy
Neoplasms
News And Views
Non-small cell lung cancer
Periodicals
Programmed Cell Death 1 Receptor
Respiratory system agents
Tumors
Windows
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Activating immune cells to destroy tumours is an effective strategy for treating an advanced lung cancer — but only for some people. Evidence that this approach has potential in early disease and as a combination therapy has now emerged. Activating immune cells to destroy tumours is an effective strategy for treating an advanced lung cancer — but only for some people. Evidence that this approach has potential in early disease and as a combination therapy has now emerged.
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-018-05312-9